NIKKEI 225
38,490.17 -347.29 (-0.89%) HANG SENG
18,424.96 -19.15 (-0.10%) CRUDE OIL
74.33 +0.26 (+0.35%) GOLD FUTURES
2,374.70 -0.80 (-0.03%) DOW
38,807.33 +96.04 (+0.25%) Bitcoin GBP
55,705.23 +427.96 (+0.77%)
AZN Jan 2026 47.500 put
| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.4500 |
| Ask | 0.9000 |
| Strike | 47.50 |
| Expiry date | 2026-01-16 |
| Day's range | 0.6000 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 51 |
Fool.co.uk2 superb FTSE 100 stocks I’d buy for a SIPP and hold for a decade
This Fool highlights a pair of excellent blue-chip stocks that he'd buy today and tuck away in a SIPP portfolio for the long run. The post 2 superb FTSE 100 stocks I’d buy for a SIPP and hold for a decade appeared first on The Motley Fool UK.
PR NewswireAbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced preliminary safety and efficacy results from its first time in human investigator-initiated trial (IIT) of C-CAR031 in connection with the Company's oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The presentation shared data indicati
ZacksAstrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Astrazeneca (AZN) closed at $78.99, marking a +1.24% move from the previous day.
